MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0002872
Sparsh Remedies Private Limited
Sparsh Remedies Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹26.54 Cr
▲ 13% YoY
Net profit · FY 2024
₹45.87 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹69.74 Lakh
EBITDA margin 2.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹42 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
123
Provident fund records
About Sparsh Remedies Private Limited
Data last updated:
Sparsh Remedies Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PTC238124. Its GSTIN is 07AASCS3410P1ZT (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shikha Bhatnagar and Vidita Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 504 Nirman Palace Pump House, Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2024, the company reported a revenue of ₹26.54 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹45.87 Lakh (net margin 1.7%) and EBITDA of ₹69.74 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 22% over five years.
The company has about 123 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹42 Lakh on record.
Sparsh Remedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0002872). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74120MH2012PTC238124
Registration Number 238124
Incorporation Date 21 November 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0002872
Recognitions & Rankings of Sparsh Remedies
Contact details
Sparsh Remedies Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 504 Nirman Palace Pump House, Mumbai, Maharashtra, India – 400093
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sparsh Remedies Private Limited, buy the company report.
Comprehensive company report
Sparsh Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sparsh Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sparsh Remedies Private Limited, buy the company report.
Financials of Sparsh Remedies Private Limited
FY 2025 filings availableSparsh Remedies Private Limited reported revenue of ₹26.54 Cr (up 13% YoY) for FY 2024.
Revenue · FY 2024
₹26.54 Cr ▲ 13%
Net profit · FY 2024
₹45.87 Lakh margin 1.7%
EBITDA · FY 2024
₹69.74 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 34%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 31%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 13% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sparsh Remedies Private Limited, buy the company report.
Board of directors of Sparsh Remedies Private Limited
Sparsh Remedies has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikha Bhatnagar | Director | 21 Nov 2012 | 13 Years 11 Months | Current |
| Vidita Jain | Director | 09 Oct 2023 | 3 Years 0 Months | Current |
| Maneesh Jain | Director | 21 Nov 2012 | 13 Years 11 Months | Current |
Peer comparison
Sparsh Remedies Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parshwa Pharma Chem Private Limited | ₹26.85 Cr (FY 2025) | -1.0% | Kalyan, Maharashtra, India | |||
| K Kyemistry (India) Private Limited | ₹26.66 Cr (FY 2024) | 1.0% | Ahmedabad, Gujarat, India | |||
| K G Life Science Private Limited | ₹26.62 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Sparsh Remedies Private Limitedthis company | ₹26.54 Cr (FY 2024) | ₹45.87 Lakh | 1.7% | 13.0% | 123 | Mumbai, Maharashtra, India |
| Ajmera Pharmasure Limited | ₹26.52 Cr (FY 2025) | -44.0% | Mumbai, Maharashtra, India | |||
| Triton Health Care Private Limited | ₹26.38 Cr (FY 2025) | 1.0% | Chennai, Tamil Nadu, India | |||
| Satyam Medical Agency Private Limited | ₹26.29 Cr (FY 2025) | 79.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sparsh Remedies Private Limited, buy the company report.
Auditor
Sparsh Remedies Private Limited is audited by NGRG & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NGRG & CO. | FY 2022 | 0015131C |
Shareholding
The shareholding of Sparsh Remedies Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sparsh Remedies Private Limited, buy the company report.
Charges & borrowings
Open charges
₹42 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2015 | 10557250 | Idbi Bank Limited | ₹42 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sparsh Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sparsh Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sparsh Remedies Private Limited has a workforce of 123 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
123
Active EPFO establishments
1
Employee growth
12.84%
GST
Sparsh Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCS3410P1ZT | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sparsh Remedies Private Limited, buy the company report.
Recent activity
Sparsh Remedies Private Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Vidita Jain ceased to be Additional Director on 29 Sep 2024.
AGM
Sparsh Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sparsh Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Vidita Jain ceased to be Additional Director.
Appointed
Vidita Jain was appointed as Director.
Ceased
Bhartesh Chand Jain ceased to be Director.
Ceased
Savita Jain ceased to be Director.
Charges
A charge with Idbi Bank Limited amounted to Rs. 42.00 Lakh with Charge ID 10557250 was registered on 25 Mar 2015.
Appointed
Maneesh Jain was appointed as Director.
Appointed
Shikha Bhatnagar was appointed as Director.
Incorporation
21 Nov 2012
Sparsh Remedies Private Limited was registered on 21 Nov 2012 with Roc Mumbai I & aged 13 years 11 months as per MCA records.
Frequently asked questions
Sparsh Remedies is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 November 2012 (14+ years old) and is registered under CIN U74120MH2012PTC238124.
Sparsh Remedies has 3 current directors:
- Shikha Bhatnagar - Director
- Vidita Jain - Director
- Maneesh Jain - Director
The latest financial statements of Sparsh Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sparsh Remedies is 07AASCS3410P1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of Sparsh Remedies is U74120MH2012PTC238124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparsh Remedies was incorporated on 21 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sparsh Remedies by revenue are Parshwa Pharma Chem Private Limited, K Kyemistry (India) Private Limited, K G Life Science Private Limited, Ajmera Pharmasure Limited, Triton Health Care Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Vidita Jain ceased to be Additional Director on 29 Sep 2024. Vidita Jain was appointed as Director on 09 Oct 2023. Bhartesh Chand Jain ceased to be Director on 21 Sep 2023. Sparsh Remedies has 6 board changes on record in total.
Yes, Sparsh Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0002872).
The registered office of Sparsh Remedies is at C – 504 Nirman Palace Pump House, Mumbai, Maharashtra, India – 400093.
Sparsh Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.